First Report of the East-Central South African Genotype of Chikungunya Virus in Rio de Janeiro, Brazil

PLoS Curr. 2017 Feb 14:9:ecurrents.outbreaks.4200119978d62ccaa454599cd2735727. doi: 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727.

Abstract

Background: Chikungunya virus (CHIKV) is an arbovirus that causes an acute febrile syndrome with a severe and debilitating arthralgia. In Brazil, the Asian and East-Central South African (ECSA) genotypes are circulating in the north and northeast of the country, respectively. In 2015, the first autochthonous cases in Rio de Janeiro, Brazil were reported but until now the circulating strains have not been characterized. Therefore, we aimed here to perform the molecular characterization and phylogenetic analysis of CHIKV strains circulating in the 2016 outbreak occurred in the municipality of Rio de Janeiro.

Methods: The cases analyzed in this study were collected at a private Hospital, from April 2016 to May 2016, during the chikungunya outbreak in Rio de Janeiro, Brazil. All cases were submitted to the Real Time RT-PCR for CHIKV genome detection and to anti-CHIKV IgM ELISA. Chikungunya infection was laboratorially confirmed by at least one diagnostic method and, randomly selected positive cases (n=10), were partially sequenced (CHIKV E1 gene) and analyzed.

Results: The results showed that all the samples grouped in ECSA genotype branch and the molecular characterization of the fragment did not reveal the A226V mutation in the Rio de Janeiro strains analyzed, but a K211T amino acid substitution was observed for the first time in all samples and a V156A substitution in two of ten samples.

Conclusions: Phylogenetic analysis and molecular characterization reveals the circulation of the ECSA genotype of CHIKV in the city of Rio de Janeiro, Brazil and two amino acids substitutions (K211T and V156A) exclusive to the CHIKV strains obtained during the 2016 epidemic, were reported.

Keywords: Brazil; Chikungunya; ECSA genotype; Rio de Janeiro; Surveillance.

Grants and funding

This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico/CNPq [grant number 303822/2015-5 to FBS], Programa Estratégico de Pesquisa em Saúde/PAPES VI-FIOCRUZ [grant number 407690/2012–3], to Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro /FAPERJ [to RMR, to ELA and to FBS], to Oswaldo Cruz Foundation/FIOCRUZ and Brazilian Ministry of Health. TMAS and PCGN are fellow by the Conselho Nacional de Desenvolvimento Científico e Tecnológico/CNPq. FBN and TCC are fellows from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). JBCS has fellowships from the Oswaldo Cruz Institute (IOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.